1.
Rev. am. med. respir
;
22(2): 253-256, jun. 2022. graf
Artigo
em Inglês
|
LILACS-Express
| LILACS
| ID: biblio-1441138
RESUMO
ABSTRACT 70-year-old male patient with chronic myeloid leukemia receiving treatment with dasatinib develops respiratory failure associated with pulmonary toxicity related to such drug.
RESUMEN Paciente de sexo masculino, 70 años, con leucemia mieloide crónica en tratamiento con dasatinib, desarrolla insuficiencia respiratoria asociada a toxicidad pulmonar por dicho fármaco.